Mendel Scott — SEC insider filings
SEC reporting owner CIK 1515051. 32 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 32 filings on record, filed 2020-08-14 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 28,500 shares, $211,860 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 8 legs across 8 filings — 231,672 shares, $3,390,294 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 45.
- Largest priced transaction: sale of 64,975 shares @ $14.23 ($924,594) in GenMark Diagnostics, Inc., filed 2021-01-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GenMark Diagnostics, Inc. (GNMK) | President & CEO, Director | 13 | — | 8 legs · 231,672 sh · $3,390,294 | 19 |
| Akoya Biosciences, Inc. (AKYA) | Director | 8 | 2 legs · 28,500 sh · $211,860 | — | 11 |
| Quanterix Corp (QTRX) | Director | 7 | — | — | 11 |
| Quantum-Si Inc (QSI) | Director | 4 | — | — | 4 |
Insider filings — Mendel Scott
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 4,398 @ $3.41 | EDGAR |
| 2026-07-09 | 4 | Quanterix Corp (QTRX) | Option exercise (M): 8,073 · Option exercise (M): 8,073 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 3,456 @ $4.34 | EDGAR |
| 2026-05-20 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 251,185 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 4,310 @ $0 | EDGAR |
| 2026-01-06 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 23,372 @ $0 · Grant/award (A): 1,944 @ $0 | EDGAR |
| 2025-10-03 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 2,084 @ $5.54 | EDGAR |
| 2025-07-10 | 4 | Quanterix Corp (QTRX) | Grant/award (A): 4,189 · Grant/award (A): 24,464 @ $0 · Grant/award (A): 50,758 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | Akoya Biosciences, Inc. (AKYA) | Other (J): 28,500 · Other (J): 35,562 (derivative) @ $0 · Other (J): 30,549 (derivative) @ $0 · Other (J): 56,322 (derivative) @ $0 · Other (J): 44,959 (derivative) @ $0 · Other (J): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 126,095 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | Akoya Biosciences, Inc. (AKYA) | Grant/award (A): 44,959 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Akoya Biosciences, Inc. (AKYA) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 113,281 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | Akoya Biosciences, Inc. (AKYA) | Purchase (P): 20,000 @ $5 | EDGAR |
| 2023-06-05 | 4 | Akoya Biosciences, Inc. (AKYA) | Grant/award (A): 56,322 (derivative) @ $0 | EDGAR |
| 2023-05-16 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 141,843 @ $0 | EDGAR |
| 2022-06-03 | 4 | Akoya Biosciences, Inc. (AKYA) | Grant/award (A): 30,549 (derivative) @ $0 | EDGAR |
| 2021-11-19 | 4 | Akoya Biosciences, Inc. (AKYA) | Purchase (P): 8,500 @ $13.16 | EDGAR |
| 2021-06-15 | 4 | Akoya Biosciences, Inc. (AKYA) | Grant/award (A): 35,562 (derivative) @ $0 | EDGAR |
| 2021-04-22 | 4 | GenMark Diagnostics, Inc. (GNMK) | Code (U): 507,198 @ $24.05 · Code (U): 115,491 @ $24.05 · Disposition to issuer (D): 28,332 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 53,382 (derivative) · Disposition to issuer (D): 84,002 (derivative) · +1 more | EDGAR |
| 2021-03-01 | 4 | GenMark Diagnostics, Inc. (GNMK) | Tax withholding (F): 41,834 @ $0 | EDGAR |
| 2021-02-25 | 4 | GenMark Diagnostics, Inc. (GNMK) | Tax withholding (F): 3,254 @ $0 | EDGAR |
| 2021-02-24 | 4 | GenMark Diagnostics, Inc. (GNMK) | Tax withholding (F): 1,860 @ $0 | EDGAR |
| 2021-02-22 | 4 | GenMark Diagnostics, Inc. (GNMK) | Tax withholding (F): 3,952 @ $0 · Grant/award (A): 80,070 @ $0 · Grant/award (A): 26,691 (derivative) @ $0 | EDGAR |
| 2021-01-25 | 4 | GenMark Diagnostics, Inc. (GNMK) | Sale (S): 64,975 @ $14.23 | EDGAR |
| 2021-01-21 | 4 | GenMark Diagnostics, Inc. (GNMK) | Sale (S): 50,000 @ $14.54 · Option exercise (M): 50,074 @ $0 · Option exercise (M): 46,098 @ $0 · Option exercise (M): 50,000 @ $0 · Option exercise (M): 50,074 (derivative) @ $0 · Option exercise (M): 46,098 (derivative) @ $0 · +1 more | EDGAR |
| 2020-11-25 | 4 | GenMark Diagnostics, Inc. (GNMK) | Sale (S): 5,190 @ $13.17 | EDGAR |
| 2020-11-20 | 4 | GenMark Diagnostics, Inc. (GNMK) | Sale (S): 3,987 @ $13.85 | EDGAR |
| 2020-08-28 | 4 | GenMark Diagnostics, Inc. (GNMK) | Sale (S): 50,000 @ $15.02 | EDGAR |
| 2020-08-26 | 4 | GenMark Diagnostics, Inc. (GNMK) | Sale (S): 4,532 @ $14.14 | EDGAR |
| 2020-08-24 | 4 | GenMark Diagnostics, Inc. (GNMK) | Sale (S): 2,988 @ $15.41 | EDGAR |
| 2020-08-14 | 4 | GenMark Diagnostics, Inc. (GNMK) | Sale (S): 50,000 @ $15.08 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1515051 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs